PTC Therapeutics has secured another significant regulatory milestone, with Health Canada granting marketing authorization ...

In a notable move, the Chief Financial Officer of MP Materials has sold a substantial portion of his holdings in the company. Ryan Corbett disposed of shares ...

The mobile advertising technology firm AppLovin is currently at the center of a significant Wall Street debate. Despite posting exceptionally strong financia ...

Rocket Lab USA is demonstrating formidable operational momentum, propelling its stock price higher as it outpaces industry delays. The company's ability to a ...

In turbulent market periods, investors typically gravitate toward defensive stocks. However, recent activity surrounding ...

New long-term clinical data for Blueprint Medicines' drug Ayvakit (avapritinib) were presented at the ASH congress in Orlando, reinforcing the treatment's pr ...

Amazon has unveiled a series of significant strategic initiatives this week, signaling a clear corporate priority on expansion and market share, even at the ...

After a recent period of declining share prices, Eli Lilly has pivoted investor focus with a major strategic push centered on ...

The biotechnology sector is characterized by significant price swings, and Regeneron Pharmaceuticals is currently navigating one such period. Although the co ...

The investment case for BioNTech presents a complex picture, caught between significant company-specific advancements and broader industry pressures. While t ...

The release of unexpectedly robust Phase 3 clinical trial data this week by healthcare giant Johnson & Johnson failed to move ...

The performance of Amphenol Corporation has captured significant market attention in recent quarters, delivering a powerful combination of soaring orders, re ...